CLINICAL_TRIALS
research
· 2026-01-22
Clinical Trial Update: Prevalence of Germline Alterations in Actionable Genes in Endometrial Cancer [NA]
Summary
This clinical trial aims to determine the prevalence of germline alterations in actionable genes among patients with endometrial cancer and is not yet recruitin…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: European Institute of Oncology | Conditions: Endometrial Cancer | NA | Status: NOT_YET_RECRUITING